Ortho-Clinical Diagnostics 

Problem statement:

OCD’s finance & accounting function had a number of operational and structural issues. This impacted the efficiency and effectiveness of the finance & accounting department, causing significant staff turnover as well as inaccuracy in financial reporting.

About OCD: Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing. Ortho serves two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood. 

Johnson and Johnson acquired Eastman Kodak‘s Clinical Diagnostics Division in 1994 (to form Johnson & Johnson Clinical Diagnostics), which was then merged with Ortho Diagnostic Systems in 1997. Ortho’s global corporate offices are in Raritan, New Jersey, while their global research and development center is in Rochester, New York.  The company is now owned by Quidel Corporation. 

Solution:  Developed a finance transformation roadmap plan to transform OCD’s finance & accounting function. 

Benefits:  Improved finance & accounting efficiency and significantly reduced staff turnover.  Also, improved its ability to produce financial and performance reports.